Nexus AG (NXU.DE)
EUR 69.4
(-0.29%)
EUR 69.4
(-0.29%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 15.43 Million EUR | 7.86% |
| 2022 | 14.31 Million EUR | 18.56% |
| 2021 | 12.07 Million EUR | 32.05% |
| 2020 | 9.14 Million EUR | 32.51% |
| 2019 | 6.89 Million EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | -100.0% |
| 2014 | 15 Thousand EUR | -65.12% |
| 2013 | 43 Thousand EUR | 0.0% |
| 2012 | - EUR | -100.0% |
| 2011 | 1.7 Million EUR | 566.8% |
| 2010 | 256 Thousand EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.36 Million EUR | 0.0% |
| 2024 Q1 | 15.36 Million EUR | 0.0% |
| 2024 Q3 | - EUR | 0.0% |
| 2023 Q2 | 15.82 Million EUR | 4.87% |
| 2023 FY | 15.43 Million EUR | 7.86% |
| 2023 Q3 | 15.21 Million EUR | -3.82% |
| 2023 Q4 | 15.43 Million EUR | 1.46% |
| 2023 Q1 | 15.08 Million EUR | 5.39% |
| 2022 Q2 | 13.25 Million EUR | 25.77% |
| 2022 Q1 | 10.53 Million EUR | -12.72% |
| 2022 FY | 14.31 Million EUR | 18.56% |
| 2022 Q4 | 14.31 Million EUR | 3.57% |
| 2022 Q3 | 13.81 Million EUR | 4.28% |
| 2021 Q3 | 12.08 Million EUR | -0.73% |
| 2021 Q1 | 9.05 Million EUR | -0.91% |
| 2021 FY | 12.07 Million EUR | 32.05% |
| 2021 Q4 | 12.07 Million EUR | -0.11% |
| 2021 Q2 | 12.17 Million EUR | 34.39% |
| 2020 Q3 | 6.73 Million EUR | 33.44% |
| 2020 FY | 9.14 Million EUR | 32.51% |
| 2020 Q4 | 9.14 Million EUR | 35.72% |
| 2020 Q2 | 5.04 Million EUR | -19.28% |
| 2020 Q1 | 6.25 Million EUR | -9.35% |
| 2019 Q3 | 6.91 Million EUR | 32.57% |
| 2019 Q4 | 6.89 Million EUR | -0.19% |
| 2019 Q1 | 5.31 Million EUR | 0.0% |
| 2019 FY | 6.89 Million EUR | 0.0% |
| 2019 Q2 | 5.21 Million EUR | -1.96% |
| 2018 FY | - EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2015 Q2 | - EUR | -100.0% |
| 2015 Q1 | 15 Thousand EUR | 0.0% |
| 2015 Q3 | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 FY | - EUR | -100.0% |
| 2014 Q2 | 24 Thousand EUR | 0.0% |
| 2014 FY | 15 Thousand EUR | -65.12% |
| 2014 Q4 | 15 Thousand EUR | 0.0% |
| 2014 Q3 | - EUR | -100.0% |
| 2014 Q1 | 24 Thousand EUR | -44.19% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q3 | - EUR | 0.0% |
| 2013 Q4 | 43 Thousand EUR | 0.0% |
| 2013 FY | 43 Thousand EUR | 0.0% |
| 2013 Q2 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | - EUR | -100.0% |
| 2012 Q3 | 523 Thousand EUR | 0.0% |
| 2012 Q4 | - EUR | -100.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q1 | 281 Thousand EUR | 9.77% |
| 2011 FY | 1.7 Million EUR | 566.8% |
| 2011 Q2 | - EUR | -100.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | 1.7 Million EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 256 Thousand EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 Q4 | 256 Thousand EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| DocCheck AG | 4.95 Million EUR | -211.458% |
| CompuGroup Medical SE & Co. KGaA | 741.08 Million EUR | 97.917% |
| MeVis Medical Solutions AG | - EUR | -Infinity% |